CD274 and neoplasm: Numerous studies have shown that antibodies targeting PD-1 or PD-L1 alleviate the inhibitory effects of PD-L1 on cytotoxic T-cells, thereby accelerating the elimination of tumor cells by cytotoxic T-cells [20].